Neuraceq
Payments companies reported to CMS as associated with Neuraceq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neuraceq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neuraceq
These are the largest totals companies reported as associated with Neuraceq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ana Franceschi | Manhasset, NY | Neuroradiology | $15,552.87 |
| Jeffrey Gelblum | Aventura, FL | Neurology (Psychiatry & Neurology) | $7,789.14 |
| Armen Moughamian | San Francisco, CA | Neurology (Psychiatry & Neurology) | $5,245.96 |
| Jeremy Ford | Boston, MA | Diagnostic Radiology | $4,523.65 |
| Giuseppe Esposito | Washington, DC | Nuclear Medicine | $1,899.69 |
| Gloria Chiang | New York, NY | Neuroradiology | $1,830.61 |
| Kevin Berger | Annapolis, MD | Diagnostic Radiology | $433.90 |
| Christian Camargo | Miami, FL | Neurology (Psychiatry & Neurology) | $433.70 |
| Salvatore Napoli | Foxboro, MA | Neurology (Psychiatry & Neurology) | $247.44 |
| Francis Conidi | Port Saint Lucie, FL | Neuromusculoskeletal Medicine & Omm | $238.97 |
Prescribed Neuraceq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.